Proof of Usefulness Report

AgThera Inc.

Analysis completed on 3/17/2026

+172

Proof of Usefulness Score

Gaining Momentum

AgThera proposes a highly innovative approach to infectious diseases using synthetic biology and machine learning. However, the submission is severely penalized for vague inputs and highly exaggerated, unverifiable claims regarding traction ('most people have used my product') for a 2021 biotechnology startup. The lack of credible metrics and poor response quality relegate this to a low-tier score despite its theoretical technical merit.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+50

Audience Reach Impact+10

Technical Innovation+80

Evidence Of Traction+0

Market Timing Relevance+50

Functional Completeness+5

Subtotal+195

Usefulness Multiplierx0.88

Final Score+172

Project Details

Project URL

agthera.com

Description

AgThera discovers a new class of antibacterial and antiviral living medicines for infectious diseases. With synthetic biology techniques we engineer hundreds of variant antimicrobial probiotics. With computational biology and machine learning we can guide engineering of these live biotherapeutics, analyze the results of experiments and design new systems for high performance. AgThera's live therapeutics are tailored to eliminate pathogens effectively and reliably.

Algorithm Insights

Market Position

Growing utility with room for optimization

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline